معرفی
Ronny Priefer is Associate Dean of Graduate Studies at the School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences (MCPHS), where he joined in 2019. He holds a PhD in Organic Chemistry from McGill University and brings extensive experience from both industry (Starks Associate, Neurochem Inc.) and academia (Western New England University, Niagara University). His academic appointments include faculty positions across multiple institutions with leadership roles in graduate education.
Dr. Priefer's research spans medicinal, analytical, educational, and materials chemistry, with a focus on diabetes, cancer, Alzheimer's disease, and antimicrobial applications. His most notable achievement was introducing a new class of polyelectrolytes into multilayering (pseudo-polyelectrolytes), which led to the launch of two spin-off companies—Breath Health and New England Breath Technologies. These companies developed a breathalyzer for screening and monitoring diabetes, with potential applications in cancer, lactose intolerance, and marijuana detection. He has also filed patents for novel Alzheimer's and cancer therapies.
His recent publications demonstrate a strong focus on regulatory science, nanomedicine, breath analysis technology, drug delivery systems, and Alzheimer's disease research. His work consistently bridges fundamental chemistry with practical medical applications, particularly in non-invasive diagnostic technologies and novel therapeutic approaches.
- 2024 Faculty Scholarship of Integration Award, MCPHS
- 2023 Gail P. & Edward A. Bucher Trustees' Award for Excellence in Student-Faculty Research Collaboration
- 2023 Leadership Awards Banquet-Student Choice Award
- 2022 Teacher of the Year, School of Pharmacy
- 2017 University of Northern British Columbia, Alumnus of the Year for Professional Excellence
- 2017 Top Award through the Valley Venture Mentor Program ($25,000)
Dr. Priefer has mentored more than 50 students at master's and PhD levels throughout his career. His research has been supported by external funding from organizations including the National Science Foundation, Massachusetts Life Sciences, TA Instruments, and the American Foundation for Pharmaceutical Education. He has also secured grants from The Massachusetts Technology Transfer Center, American Chemical Society, American Society for Quality, and New York State Great Lakes Protection Fund. His lab focuses on multilayer film technology, breath analysis, and novel drug delivery systems with applications across multiple disease states.
